EPI.AU Epiminder Ltd
- Market cap
- AUD 57.4M
- P/E
- -
- P/B
- 0.70x
- ROE
- -52.3%
- Dividend yield
- -
- Fundamental score
- 0.5/5
Ratios use the latest price and the fiscal year ending Jun 2026.
Is EPI.AU undervalued?
Graham numberThe Graham number of Epiminder Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Epiminder Ltd fundamental analysis
3 of 21 checks passedROE 0/2
Low return on equity (-52.3%), below 10%.
ROA 0/1
Return on assets (-47.0%) is below the industry median (-7.4%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (-8.7%) is below the industry median (5.2%).
Revenue Growth 0/2
Revenue did not grow over the past 3 years or is not reported.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Cash Runway 0/2
Cash runway cannot be calculated.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 1/1
Price to book (0.7x) is below the industry median (2.5x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Epiminder Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Epiminder Ltd
Epiminder Limited engages in the development and manufacture of monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. The company offers Minder system, an electroencephalographic (EEG) recording and transmitting device implanted under the scalp. Its Minder system comprises Minder Implant, a sub scalp electrode with multiple recording points which enables capture of EEG continuously for months or years; Minder Wearable, w…
Full company profileEpiminder Ltd financial statements
Epiminder Ltd annual financial statements (AUD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | 5.49M | 6.56M | 445K | - |
| Gross Profit | - | - | - | -4.00M |
| Operating Income | -15.1M | -14.1M | -29.8M | -43.6M |
| Net Income | -16.1M | -15.9M | -31.8M | -42.7M |
| EPS | -0.07 | -0.07 | -0.18 | -0.20 |
| Balance Sheet | ||||
| Total Assets | 36.6M | 34.2M | 131M | 90.8M |
| Total Liabilities | 35.2M | 42.0M | 23.3M | 9.17M |
| Shareholders' Equity | 1.39M | -7.79M | 107M | 81.7M |
| Cash & Short-term Investments | 11.2M | 11.3M | 8.85M | 75.8M |
| Cash Flow | ||||
| Operating Cash Flow | -14.2M | -13.8M | -17.0M | - |
| Capital Expenditure | 25.2K | 49.8K | 38.2K | 0.00 |
| Ratios | ||||
| ROE | -1,155.4% | - | -29.6% | -52.3% |
| ROA | -44.0% | -46.6% | -24.3% | -47.0% |
| Net Profit Margin | -292.7% | -242.5% | -7,138.5% | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Epiminder Ltd dividends
Epiminder Ltd has not paid dividends in the last 4 fiscal years.
Who owns Epiminder Ltd
- Insiders 67.38%
- Institutions 14.20%
- Public & others 18.43%
- Shares outstanding 217M
- Free float 117M
Epiminder Ltd company profile
- Company name
- Epiminder Ltd
- Ticker
- EPI.AU
- ISIN
- AU0000432239
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Fiscal year end
- June
- Address
- West Podium, Mezzanine 2, Melbourne, VIC, Australia, 3000
- Phone
- 61 4 5252 1634
- Website
- epiminder.com
About Epiminder Ltd
Epiminder Limited engages in the development and manufacture of monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. The company offers Minder system, an electroencephalographic (EEG) recording and transmitting device implanted under the scalp. Its Minder system comprises Minder Implant, a sub scalp electrode with multiple recording points which enables capture of EEG continuously for months or years; Minder Wearable, which receives and stores EEG recordings wirelessly transmitted from the Minder implant to the Minder app; Minder App that collects and transmits EEG data from the Minder implant via Bluetooth and uploads to the Minder Cloud for processing; and Minder Cloud, a secure, online portal which allows healthcare professionals to download patient data. The company was incorporated in 2017 and is based in Melbourne, Australia.
Epiminder Ltd management
6- Dr. Rohan J. Hoare Ph.D.CEO, MD & Director · born 1964
- Mr. Mark McLellanCFO & Company Secretary
- Dr. John HeasmanChief Operating Officer
- Prof. Mark Cook A.O.Founder & Chief Medical Officer
- Mr. Toby McSweeneyChief Technology Officer
- Ms. Belinda Ann Cleminson BEd, GIA (Cert)Joint Company Secretary